{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T17:52:16Z","timestamp":1784137936922,"version":"3.55.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T00:00:00Z","timestamp":1537315200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T00:00:00Z","timestamp":1537315200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA033930"],"award-info":[{"award-number":["R01DA033930"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["F30 DA037649."],"award-info":[{"award-number":["F30 DA037649."]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s00213-018-5029-y","type":"journal-article","created":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T17:54:28Z","timestamp":1537379668000},"page":"1057-1066","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Effects of repeated treatment with methcathinone, mephedrone, and fenfluramine on intracranial self-stimulation in rats"],"prefix":"10.1007","volume":"236","author":[{"given":"J. A.","family":"Suyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. L.","family":"Banks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. S.","family":"Negus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,19]]},"reference":[{"key":"5029_CR1","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1097\/FBP.0b013e32834aff54","volume":"22","author":"AA Altarifi","year":"2011","unstructured":"Altarifi AA, Negus SS (2011) Some determinants of morphine effects on intracranial self-stimulation in rats: dose, pretreatment time, repeated treatment, and rate dependence. Behav Pharmacol 22:663\u2013673","journal-title":"Behav Pharmacol"},{"key":"5029_CR2","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1097\/FBP.0b013e328358593c","volume":"23","author":"AA Altarifi","year":"2012","unstructured":"Altarifi AA, Miller LL, Negus SS (2012) Role of micro-opioid receptor reserve and micro-agonist efficacy as determinants of the effects of micro-agonists on intracranial self-stimulation in rats. Behav Pharmacol 23:678\u2013692","journal-title":"Behav Pharmacol"},{"key":"5029_CR3","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1097\/FBP.0b013e328364c0bd","volume":"24","author":"AA Altarifi","year":"2013","unstructured":"Altarifi AA, Rice KC, Negus SS (2013) Abuse-related effects of micro-opioid analgesics in an assay of intracranial self-stimulation in rats: modulation by chronic morphine exposure. Behav Pharmacol 24:459\u2013470","journal-title":"Behav Pharmacol"},{"key":"5029_CR4","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1111\/j.1476-5381.2012.02214.x","volume":"168","author":"CT Bauer","year":"2013","unstructured":"Bauer CT, Banks ML, Blough BE, Negus SS (2013) Use of intracranial self-stimulation to evaluate abuse-related and abuse-limiting effects of monoamine releasers in rats. Br J Pharmacol 168:850\u2013862","journal-title":"Br J Pharmacol"},{"key":"5029_CR5","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1007\/s00213-013-3405-1","volume":"231","author":"CT Bauer","year":"2014","unstructured":"Bauer CT, Banks ML, Negus SS (2014) The effect of chronic amphetamine treatment on cocaine-induced facilitation of intracranial self-stimulation in rats. Psychopharmacology 231:2461\u20132470","journal-title":"Psychopharmacology"},{"key":"5029_CR6","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.1007\/s00213-015-3982-2","volume":"232","author":"CT Bauer","year":"2015","unstructured":"Bauer CT, Banks ML, Blough BE, Negus SS (2015) Role of 5-HT(2)C receptors in effects of monoamine releasers on intracranial self-stimulation in rats. Psychopharmacology 232:3249\u20133258","journal-title":"Psychopharmacology"},{"key":"5029_CR7","doi-asserted-by":"publisher","first-page":"15150","DOI":"10.1523\/JNEUROSCI.3223-14.2014","volume":"34","author":"MH Baumann","year":"2014","unstructured":"Baumann MH, Solis E Jr, Watterson LR, Marusich JA, Fantegrossi WE, Wiley JL (2014) Baths salts, spice, and related designer drugs: the science behind the headlines. J Neurosci 34:15150\u201315158","journal-title":"J Neurosci"},{"key":"5029_CR8","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s00213-013-3223-5","volume":"231","author":"JS Bonano","year":"2014","unstructured":"Bonano JS, Glennon RA, De Felice LJ, Banks ML, Negus SS (2014) Abuse-related and abuse-limiting effects of methcathinone and the synthetic \u201cbath salts\u201d cathinone analogs methylenedioxypyrovalerone (MDPV), methylone and mephedrone on intracranial self-stimulation in rats. Psychopharmacology 231:199\u2013207","journal-title":"Psychopharmacology"},{"key":"5029_CR9","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1111\/bph.13030","volume":"172","author":"JS Bonano","year":"2015","unstructured":"Bonano JS, Banks ML, Kolanos R, Sakloth F, Barnier ML, Glennon RA, Cozzi NV, Partilla JS, Baumann MH, Negus SS (2015) Quantitative structure-activity relationship analysis of the pharmacology of para-substituted methcathinone analogues. Br J Pharmacol 172:2433\u20132444","journal-title":"Br J Pharmacol"},{"key":"5029_CR10","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1111\/adb.12069","volume":"19","author":"S Bradbury","year":"2014","unstructured":"Bradbury S, Bird J, Colussi-Mas J, Mueller M, Ricaurte G, Schenk S (2014) Acquisition of MDMA self-administration: pharmacokinetic factors and MDMA-induced serotonin release. Addict Biol 19:874\u2013884","journal-title":"Addict Biol"},{"key":"5029_CR11","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.1038\/nprot.2007.441","volume":"2","author":"WA Carlezon Jr","year":"2007","unstructured":"Carlezon WA Jr, Chartoff EH (2007) Intracranial self-stimulation (ICSS) in rodents to study the neurobiology of motivation. Nat Protoc 2:2987\u20132995","journal-title":"Nat Protoc"},{"key":"5029_CR12","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0006-3223(02)01730-4","volume":"54","author":"JF Cryan","year":"2003","unstructured":"Cryan JF, Hoyer D, Markou A (2003) Withdrawal from chronic amphetamine induces depressive-like behavioral effects in rodents. Biol Psychiatry 54:49\u201358","journal-title":"Biol Psychiatry"},{"key":"5029_CR13","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/0306-4603(89)90055-5","volume":"14","author":"CB Dahl","year":"1989","unstructured":"Dahl CB, Gotestam KG (1989) Lack of self-administration of different fenfluramine isomers in rats. Addict Behav 14:239\u2013247","journal-title":"Addict Behav"},{"key":"5029_CR14","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.lfs.2013.10.029","volume":"97","author":"LJ De Felice","year":"2014","unstructured":"De Felice LJ, Glennon RA, Negus SS (2014) Synthetic cathinones: chemical phylogeny, physiology, and neuropharmacology. Life Sci 97:20\u201326","journal-title":"Life Sci"},{"key":"5029_CR15","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/j.1369-1600.2011.00370.x","volume":"18","author":"J Do","year":"2013","unstructured":"Do J, Schenk S (2013) Self-administered MDMA produces dose- and time-dependent serotonin deficits in the rat brain. Addict Biol 18:441\u2013447","journal-title":"Addict Biol"},{"key":"5029_CR16","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1037\/pha0000055","volume":"24","author":"K Freitas","year":"2016","unstructured":"Freitas K, Carroll FI, Negus SS (2016) Comparison of effects produced by nicotine and the alpha4beta2-selective agonist 5-I-A-85380 on intracranial self-stimulation in rats. Exp Clin Psychopharmacol 24:65\u201375","journal-title":"Exp Clin Psychopharmacol"},{"key":"5029_CR17","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.drugalcdep.2015.01.022","volume":"150","author":"TW Grim","year":"2015","unstructured":"Grim TW, Wiebelhaus JM, Morales AJ, Negus SS, Lichtman AH (2015) Effects of acute and repeated dosing of the synthetic cannabinoid CP55,940 on intracranial self-stimulation in mice. Drug Alcohol Depend 150:31\u201337","journal-title":"Drug Alcohol Depend"},{"key":"5029_CR18","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1007\/s00213-014-3451-3","volume":"231","author":"TM Hillhouse","year":"2014","unstructured":"Hillhouse TM, Porter JH, Negus SS (2014) Dissociable effects of the noncompetitive NMDA receptor antagonists ketamine and MK-801 on intracranial self-stimulation in rats. Psychopharmacology 231:2705\u20132716","journal-title":"Psychopharmacology"},{"key":"5029_CR19","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1038\/npp.2017.2","volume":"42","author":"WS John","year":"2017","unstructured":"John WS, Martin TJ, Nader MA (2017) Behavioral determinants of cannabinoid self-administration in Old World Monkeys. Neuropsychopharmacology 42:1522\u20131530","journal-title":"Neuropsychopharmacology"},{"key":"5029_CR20","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1038\/s41386-018-0071-3","volume":"43","author":"AR Johnson","year":"2018","unstructured":"Johnson AR, Banks ML, Selley DE, Negus SS (2018) Amphetamine maintenance differentially modulates effects of cocaine, methylenedioxypyrovalerone (MDPV), and methamphetamine on intracranial self-stimulation and nucleus accumbens dopamine in rats. Neuropsychopharmacology 43:1753\u20131762","journal-title":"Neuropsychopharmacology"},{"key":"5029_CR21","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1177\/096032719201100108","volume":"11","author":"P Kintz","year":"1992","unstructured":"Kintz P, Mangin P (1992) Toxicological findings after fatal fenfluramine self-poisoning. Hum Exp Toxicol 11:51\u201352","journal-title":"Hum Exp Toxicol"},{"key":"5029_CR22","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S0022-3565(25)22172-3","volume":"246","author":"MS Kleven","year":"1988","unstructured":"Kleven MS, Schuster CR, Seiden LS (1988) Effect of depletion of brain serotonin by repeated fenfluramine on neurochemical and anorectic effects of acute fenfluramine. J Pharmacol Exp Ther 246:822\u2013828","journal-title":"J Pharmacol Exp Ther"},{"key":"5029_CR23","first-page":"2473","volume":"38","author":"C Kornetsky","year":"1979","unstructured":"Kornetsky C, Esposito RU (1979) Euphorigenic drugs: effects on the reward pathways of the brain. Fed Proc 38:2473\u20132476","journal-title":"Fed Proc"},{"key":"5029_CR24","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1124\/jpet.112.197780","volume":"343","author":"AJ Kwilasz","year":"2012","unstructured":"Kwilasz AJ, Negus SS (2012) Dissociable effects of the cannabinoid receptor agonists Delta9-tetrahydrocannabinol and CP55940 on pain-stimulated versus pain-depressed behavior in rats. J Pharmacol Exp Ther 343:389\u2013400","journal-title":"J Pharmacol Exp Ther"},{"key":"5029_CR25","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.jsxm.2015.12.031","volume":"13","author":"MF Lazenka","year":"2016","unstructured":"Lazenka MF, Blough BE, Negus SS (2016) Preclinical abuse potential assessment of flibanserin: effects on intracranial self-stimulation in female and male rats. J Sex Med 13:338\u2013349","journal-title":"J Sex Med"},{"key":"5029_CR26","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1124\/jpet.117.246215","volume":"365","author":"LP Legakis","year":"2018","unstructured":"Legakis LP, Negus SS (2018) Repeated morphine produces sensitization to reward and tolerance to antiallodynia in male and female rats with chemotherapy-induced neuropathy. J Pharmacol Exp Ther 365:9\u201319","journal-title":"J Pharmacol Exp Ther"},{"key":"5029_CR27","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1037\/pha0000042","volume":"23","author":"LL Miller","year":"2015","unstructured":"Miller LL, Altarifi AA, Negus SS (2015a) Effects of repeated morphine on intracranial self-stimulation in male rats in the absence or presence of a noxious pain stimulus. Exp Clin Psychopharmacol 23:405\u2013414","journal-title":"Exp Clin Psychopharmacol"},{"key":"5029_CR28","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.pain.0000000000000018","volume":"156","author":"LL Miller","year":"2015","unstructured":"Miller LL, Leitl MD, Banks ML, Blough BE, Negus SS (2015b) Effects of the triple monoamine uptake inhibitor amitifadine on pain-related depression of behavior and mesolimbic dopamine release in rats. Pain 156:175\u2013184","journal-title":"Pain"},{"key":"5029_CR29","unstructured":"National Research Council (2011) Guide for the Care and Use of Laboratory Animals, 8th ed. The National Academies Press, Washington D.C."},{"key":"5029_CR30","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/7854_2016_18","volume":"32","author":"SS Negus","year":"2017","unstructured":"Negus SS, Banks ML (2017) Decoding the structure of abuse potential for new psychoactive substances: structure-activity relationships for abuse-related effects of 4-substituted methcathinone analogs. Curr Top Behav Neurosci 32:119\u2013131","journal-title":"Curr Top Behav Neurosci"},{"key":"5029_CR31","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1124\/pr.112.007419","volume":"66","author":"SS Negus","year":"2014","unstructured":"Negus SS, Miller LL (2014) Intracranial self-stimulation to evaluate abuse potential of drugs. Pharmacol Rev 66:869\u2013917","journal-title":"Pharmacol Rev"},{"key":"5029_CR32","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0022-3565(24)37596-2","volume":"286","author":"SS Negus","year":"1998","unstructured":"Negus SS, Gatch MB, Mello NK, Zhang X, Rice K (1998) Behavioral effects of the delta-selective opioid agonist SNC80 and related compounds in rhesus monkeys. J Pharmacol Exp Ther 286:362\u2013375","journal-title":"J Pharmacol Exp Ther"},{"key":"5029_CR33","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.jpain.2011.12.003","volume":"13","author":"SS Negus","year":"2012","unstructured":"Negus SS, Rosenberg MB, Altarifi AA, O'Connell RH, Folk JE, Rice KC (2012) Effects of the delta opioid receptor agonist SNC80 on pain-related depression of intracranial self-stimulation (ICSS) in rats. J Pain 13:317\u2013327","journal-title":"J Pain"},{"key":"5029_CR34","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/0014-2999(92)90432-4","volume":"216","author":"ME Olds","year":"1992","unstructured":"Olds ME, Yuwiler A (1992) Effects of acute and chronic fenfluramine on self-stimulation and its facilitation by amphetamine. Eur J Pharmacol 216:363\u2013372","journal-title":"Eur J Pharmacol"},{"key":"5029_CR35","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.biopsych.2011.05.021","volume":"70","author":"DN Potter","year":"2011","unstructured":"Potter DN, Damez-Werno D, Carlezon WA Jr, Cohen BM, Chartoff EH (2011) Repeated exposure to the kappa-opioid receptor agonist salvinorin A modulates extracellular signal-regulated kinase and reward sensitivity. Biol Psychiatry 70:744\u2013753","journal-title":"Biol Psychiatry"},{"key":"5029_CR36","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/978-1-4612-4812-5_19","volume-title":"Methods of assessing the reinforcing properties of abused drugs","author":"LD Reid","year":"1987","unstructured":"Reid LD (1987) Tests involving pressing for intracranial stimulation as an early procedure for screening the likelihood of addiction of opioids and other drugs. In: Bozarth MJ (ed) Methods of assessing the reinforcing properties of abused drugs. Springer-Verlag, Berlin, pp 391\u2013420"},{"key":"5029_CR37","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1016\/j.neuropharm.2011.12.011","volume":"62","author":"TT Riday","year":"2012","unstructured":"Riday TT, Kosofsky BE, Malanga CJ (2012) The rewarding and locomotor-sensitizing effects of repeated cocaine administration are distinct and separable in mice. Neuropharmacology 62:1858\u20131866","journal-title":"Neuropharmacology"},{"key":"5029_CR38","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.bbr.2012.06.012","volume":"234","author":"JE Robinson","year":"2012","unstructured":"Robinson JE, Agoglia AE, Fish EW, Krouse MC, Malanga CJ (2012) Mephedrone (4-methylmethcathinone) and intracranial self-stimulation in C57BL\/6J mice: comparison to cocaine. Behav Brain Res 234:76\u201381","journal-title":"Behav Brain Res"},{"key":"5029_CR39","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.jpain.2012.11.006","volume":"14","author":"MB Rosenberg","year":"2013","unstructured":"Rosenberg MB, Carroll FI, Negus SS (2013) Effects of monoamine reuptake inhibitors in assays of acute pain-stimulated and pain-depressed behavior in rats. J Pain 14:246\u2013259","journal-title":"J Pain"},{"key":"5029_CR40","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3","volume":"39","author":"RB Rothman","year":"2001","unstructured":"Rothman RB, Baumann MH, Dersch CM, Romero DV, Rice KC, Carroll FI, Partilla JS (2001) Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse 39:32\u201341","journal-title":"Synapse"},{"key":"5029_CR41","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/BF00429011","volume":"81","author":"N Rowland","year":"1983","unstructured":"Rowland N, Carlton J (1983) Different behavioral mechanisms underlie tolerance to the anorectic effects of fenfluramine and quipazine. Psychopharmacology 81:155\u2013157","journal-title":"Psychopharmacology"},{"issue":"7 Suppl","key":"5029_CR42","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0195-6663(86)80053-8","volume":"7","author":"NE Rowland","year":"1986","unstructured":"Rowland NE, Carlton J (1986) Tolerance to fenfluramine anorexia: fact or fiction? Appetite 7(7 Suppl):71\u201383","journal-title":"Appetite"},{"key":"5029_CR43","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1159\/000253549","volume":"60","author":"S Schenk","year":"2009","unstructured":"Schenk S (2009) MDMA self-administration in laboratory animals: a summary of the literature and proposal for future research. Neuropsychobiology 60:130\u2013136","journal-title":"Neuropsychobiology"},{"key":"5029_CR44","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.1111\/j.1460-9568.2007.05932.x","volume":"26","author":"S Schenk","year":"2007","unstructured":"Schenk S, Hely L, Lake B, Daniela E, Gittings D, Mash DC (2007) MDMA self-administration in rats: acquisition, progressive ratio responding and serotonin transporter binding. Eur J Neurosci 26:3229\u20133236","journal-title":"Eur J Neurosci"},{"key":"5029_CR45","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/S0022-3565(25)24024-1","volume":"271","author":"G Schulteis","year":"1994","unstructured":"Schulteis G, Markou A, Gold LH, Stinus L, Koob GF (1994) Relative sensitivity to naloxone of multiple indices of opiate withdrawal: a quantitative dose-response analysis. J Pharmacol Exp Ther 271:1391\u20131398","journal-title":"J Pharmacol Exp Ther"},{"key":"5029_CR46","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1124\/jpet.115.229559","volume":"356","author":"JA Suyama","year":"2016","unstructured":"Suyama JA, Sakloth F, Kolanos R, Glennon RA, Lazenka MF, Negus SS, Banks ML (2016) Abuse-related neurochemical effects of para-substituted methcathinone analogs in rats: microdialysis studies of nucleus accumbens dopamine and serotonin. J Pharmacol Exp Ther 356:182\u2013190","journal-title":"J Pharmacol Exp Ther"},{"key":"5029_CR47","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1007\/s00213-017-4554-4","volume":"234","author":"R van de Wetering","year":"2017","unstructured":"van de Wetering R, Schenk S (2017) Repeated MDMA administration increases MDMA-produced locomotor activity and facilitates the acquisition of MDMA self-administration: role of dopamine D2 receptor mechanisms. Psychopharmacology 234:1155\u20131164","journal-title":"Psychopharmacology"},{"key":"5029_CR48","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0736-4679(97)00289-8","volume":"16","author":"LE Vivero","year":"1998","unstructured":"Vivero LE, Anderson PO, Clark RF (1998) A close look at fenfluramine and dexfenfluramine. J Emerg Med 16:197\u2013205","journal-title":"J Emerg Med"},{"key":"5029_CR49","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/BF02246185","volume":"120","author":"Y Wang","year":"1995","unstructured":"Wang Y, Joharchi N, Fletcher PJ, Sellers EM, Higgins GA (1995) Further studies to examine the nature of dexfenfluramine-induced suppression of heroin self-administration. Psychopharmacology 120:134\u2013141","journal-title":"Psychopharmacology"},{"key":"5029_CR50","doi-asserted-by":"crossref","unstructured":"Watterson LR, Hood L, Sewalia K, Tomek SE, Yahn S, Johnson CT, Wegner S, Blough BE, Marusich JA, Olive MF (2012) The reinforcing and rewarding effects of methylone, a synthetic cathinone commonly found in \u201cbath salts\u201d. J Addict Res Ther Suppl 9","DOI":"10.4172\/2155-6105.S9-002"},{"key":"5029_CR51","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/j.1369-1600.2012.00474.x","volume":"19","author":"LR Watterson","year":"2014","unstructured":"Watterson LR, Kufahl PR, Nemirovsky NE, Sewalia K, Grabenauer M, Thomas BF, Marusich JA, Wegner S, Olive MF (2014) Potent rewarding and reinforcing effects of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV). Addict Biol 19:165\u2013174","journal-title":"Addict Biol"},{"key":"5029_CR52","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.pbb.2006.05.022","volume":"84","author":"S Wee","year":"2006","unstructured":"Wee S, Woolverton WL (2006) Self-administration of mixtures of fenfluramine and amphetamine by rhesus monkeys. Pharmacol Biochem Behav 84:337\u2013343","journal-title":"Pharmacol Biochem Behav"},{"key":"5029_CR53","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1124\/jpet.115.228940","volume":"356","author":"JM Wiebelhaus","year":"2016","unstructured":"Wiebelhaus JM, Walentiny DM, Beardsley PM (2016) Effects of acute and repeated administration of oxycodone and naloxone-precipitated withdrawal on intracranial self-stimulation in rats. J Pharmacol Exp Ther 356:43\u201352","journal-title":"J Pharmacol Exp Ther"},{"key":"5029_CR54","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/S0022-3565(25)32735-7","volume":"218","author":"AM Young","year":"1981","unstructured":"Young AM, Woods JH (1981) Maintenance of behavior by ketamine and related compounds in rhesus monkeys with different self-administration histories. J Pharmacol Exp Ther 218:720\u2013727","journal-title":"J Pharmacol Exp Ther"},{"key":"5029_CR55","first-page":"75","volume":"37","author":"AM Young","year":"1981","unstructured":"Young AM, Herling S, Woods JH (1981) History of drug exposure as a determinant of drug self-administration. NIDA Res Monogr 37:75\u201388","journal-title":"NIDA Res Monogr"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-018-5029-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-018-5029-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-018-5029-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T22:16:42Z","timestamp":1751926602000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-018-5029-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,19]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["5029"],"URL":"https:\/\/doi.org\/10.1007\/s00213-018-5029-y","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,19]]},"assertion":[{"value":"30 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All animal use protocols were approved by the Virginia Commonwealth University Institutional Animal Care and Use Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}]}}